The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

President-elect Donald Trump has asked the Supreme Court to delay implementation of the law banning TikTok. Western officials say North Korean soldiers are dying in high numbers along the Ukrainian ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

Eli Lilly continues to break new ground. Its famous weight loss medicine, Zepbound (tirzepatide), just became the first to ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new study shows.

The U.S. Food and Drug Administration (FDA) has proposed a new rule to require standardized testing of talc-containing ...

Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...